US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 8.410
  • +0.220+2.69%
Close Aug 23 16:00 ET
  • 8.650
  • +0.240+2.85%
Post 20:01 ET
513.43MMarket Cap-1134P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sage Therapeutics Q2 2024 Earnings Date

Currency：USDJul 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
9.00M
8.65M
-347.94K
Miss Est.
+263.86%
+249.80%
-3.87%
EPS
-1.65
-1.70
-0.05
Miss Est.
+38.45%
+36.57%
-3.07%
Analyst Rating
Hold

Aug 24, 2024

Sage Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 18 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 12.589M--
--2024/Q3-- / 10.289M--
Jul 31, 20242024/Q28.654M / 9.002M--
Apr 25, 20242024/Q17.902M / 5.187M--
Feb 14, 20242023/Q477.972M / 60.976M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 12.589M--
--2024/Q3-- / 10.289M--
Jul 31, 20242024/Q28.654M / 9.002M--
Apr 25, 20242024/Q17.902M / 5.187M--
Feb 14, 20242023/Q477.972M / 60.976M--

Unlock Free Earnings Estimates

Sage Therapeutics Earnings Reports

  • Sage Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 31 16:19 ET

  • Sage Therapeutics | 10-Q: Q1 2024 Earnings Report

    Apr 25 07:20 ET

  • Sage Therapeutics | 10-K: FY2023 Annual Report

    Feb 14 07:22 ET

  • Sage Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 07:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 24, 2024

    Hold

    • Buy

      15.39%

    • Hold

      69.23%

    • Sell

      15.39%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg